Yale University

Affiliated Projects

Project Title Principal Investigator(s) Funder Project Period Start Project Period Endsort icon Funding Mechanism Further Detail
1 Improving the Hepatitis C Cascade of Care Among HIV/HCV Coinfected Persons of Color in Connecticut Merceditas Villanueva, M.D. Health Resources and Services Administration (HRSA)
2 HERO (Housing and Employment Resources to Improve HIV Outcomes) Health Resources and Services Administration (HRSA)
3 MATCH (Minority Addiction Treatment Co-Location with HIV Services) Frederick L Altice, M.D. Substance Abuse and Mental Health Services Administration (SAMHSA)
4 Rapid Assessment and Response to Substance Use and Risk of HIV and Other Blood-Borne Infections Among Displaced Populations in Beirut, Lebanon Kaveh Khoshnood, Ph.D., M.P.H. National Institute of Mental Health CIRA Pilot Project
5 A Theory-informed Education and Counseling Intervention for HIV-TB Treatment Adherence (TEACH) in South Africa and Uganda Luke Davis, M.D. National Institute of Mental Health CIRA Pilot Project
6 A Theory-informed Education and Counseling Intervention for HIV-TB Treatment Adherence (TEACH) in South Africa and Uganda Sheela V. Shenoi, M.D.,M.P.H National Institute of Mental Health CIRA Pilot Project
7 Using Web-based Peer Support to Increase HIV Testing Among Men who have Sex with Men in Kenya DeAnne Turner, Ph.D., M.P.H. National Institute of Mental Health CIRA Pilot Project
8 Vulnerability for Drug Abuse in Children Kathleen R. Merikangas, Ph.D. National Institute on Drug Abuse 06/01/1995 05/31/2000 R01
9 Vulnerability for Drug Abuse in Children (Supplement) Kathleen R. Merikangas, Ph.D. National Institute on Drug Abuse 06/01/1995 05/31/2000 R01
10 Impediments to Syringe Exchange Use by Minority Women Robert Heimer, Ph.D. National Institute of Mental Health 08/01/1999 07/31/2000
11 Risk Behavior and Functioning in HIV-Affected Adolescents Robert A. Murphy, Ph.D. CIRA 09/01/1999 08/31/2000 CIRA Pilot
12 Acceptance, Clinical Usefulness and Specificity of Rapid HIV Tests for Women in Late Pregnancy and Labor CIRA 09/01/1999 06/30/2001 CIRA Pilot
13 A Feasibility Study on Non-Occupational HIV Post-Exposure the Emergency Department Setting Gail D'Onofrio, M.D. CIRA 07/01/2000 07/01/2001 CIRA Pilot
14 HIV Transmission Among Minority Children at Risk for Alcohol Related Problems Kathleen R. Merikangas, Ph.D. National Institute on Alcohol Abuse and Alcoholism 02/01/1995 01/31/2002 R01
15 Drug Use and AIDS Risk Patterns of Drug User Romantic Dyads Janie Simmons, Ed.D. CIRA 09/01/1999 03/01/2002 CIRA Pilot
16 Rectal and Vaginal Dendritic Cells in SIV Infection Akiko Iwasaki, Ph.D. amfAR 06/01/2001 05/31/2002
17 Connecticut Syringe Exchanges and Early Intervention Packages Lauretta Grau, Ph.D. Drug Policy Foundation 07/01/2000 06/30/2002
18 Addressing Social Emotions to Encourage STD Prevention Behaviors, the Wear It! Project Loraine Devos-Comby, Ph.D. CIRA 07/01/2001 07/31/2002 CIRA Pilot
19 Phenotype and Genotype of HIV-1 Strains from Children Warren A. Andiman, M.D. National Institute of Allergy and Infectious Disease 08/01/1996 07/31/2002 R01
20 A Pilot Study of Mandatory HIV Counseling and Voluntary Testing of Pregnant Women in Urumqui, the Capital City of Xinjiang in China Michael H. Merson, M.D. World AIDS Foundation 01/01/2001 08/31/2002
21 A Qualitative and Quantitative Analysis of Perceived Risk of HIV Gary J. Burkholder Jr., Ph.D. CIRA 03/01/2001 08/31/2002 CIRA Pilot
22 Nursing Intervention to Improve Antiviral Adherence Ann B. Williams, R.N.C., Ed.D. National Institute of Nursing Research 09/30/1998 08/31/2002
23 Public Health Impact and Cost-Effectiveness of HIV Interventions Edward H. Kaplan, Ph.D. National Institute on Drug Abuse 06/15/1996 08/31/2002 R01
24 Reducing High Risk Behavior in HIV Positive Drug Abusers S. Kelly Avants, Ph.D. National Institute on Drug Abuse 09/30/1996 08/31/2002 R01
25 Reducing HIV Risk Behaviors Among Homeless Women Connie Nickou, Psy. D CIRA 09/01/2001 08/31/2002 CIRA Pilot
26 Structural Interventions to Reduce HIV Incidence in Drug Users Kim M. Blankenship, Ph.D. Centers for Disease Control 09/30/1999 09/29/2002
27 Simulating HIV-1 Transmission Risks among IDUs Robert Heimer, Ph.D. National Institute on Drug Abuse 06/15/1996 12/31/2002 R01
28 Optimizing Auricular Acupuncture for HIV+ Drug Abusers Arthur Margolin, Ph.D. National Institute on Drug Abuse 04/10/1999 03/31/2003
29 The Social Context of Sexual Behavior and HIV Transmission in an Agricultural Plantation Community: An Ethnographic and Epidemiological Study of Sugar Estate Workers in Northern Tanzania Eric Worby, Ph.D. CIRA 04/01/2002 03/31/2003 CIRA Pilot
30 Sexual Partnership Characteristics, Patterns, and Condom Use Among Persons Infected With HIV Linda Niccolai, Ph.D. CIRA 04/15/2002 04/14/2003 CIRA Pilot
31 Faith-Based HIV Prevention Initiatives in Africa Kari Hartwig, Dr. P.H., M.A. Fogarty International Center 05/01/2002 04/30/2003
32 Syringe Access and HIV Risk National Institute on Drug Abuse 05/05/1999 04/30/2003 R01
33 Comprehensive Search of Research on Programs Targeted Towards the Disabled with AIDS or at Risk to AIDS Internationally Nora Ellen Groce, Ph.D. CIRA 05/10/2002 05/09/2003
34 Interactive Effects of Alcohol and Polydrug Use on Sexual Risk Taking among Youth Cross Nationally Jean J. Schensul, Ph.D. CIRA 05/10/2002 05/09/2003
35 What We Can Learn About the Introduction and Acceptance of the Female Condom Through International Example Laurie Sylla, B.S.W, M.H.S.A. CIRA 05/10/2002 05/09/2003
36 Illicit Opiate Use in Maine Robert Heimer, Ph.D. Purdue-Pharma LLP 06/01/2002 05/30/2003
37 Comprehensive Elementary School AIDS Education David J. Schonfeld, M.D. National Institute of Child Health and Human Development 09/01/1998 07/31/2003
38 HIV Sex Risk Among Migrant Farmworkers in the Connecticut River Valley Michael Duke, Ph.D. CIRA 05/01/2000 07/31/2003 CIRA Pilot
39 The Classification of Government HIV/AIDS Prevention Regimes: A Cross-National Pilot Study Evan Lieberman, Ph.D. CIRA 09/01/2001 07/31/2003 CIRA Pilot
40 Female Condom Use in High-Risk Women as Predictor of Microbicide Readiness Margaret R. Weeks, Ph.D. Office of AIDS Research 09/01/2002 08/31/2003
41 A Cross-Cultural Analysis of the Role of Families in Harm Reduction Kaveh Khoshnood, Ph.D., M.P.H. CIRA 11/07/2002 11/06/2003
42 Literature and Good Practice Review: Strategic Approaches to Care for Orphaned and Vulnerable Children Shelley Geballe, J.D. CIRA 08/11/2002 11/07/2003
43 Culturing HIV in Denguele, Cote d'Ivoire: From the Ethnography of Illness and Healing To Performance Interventions With Local Networks of Hunter-Healers, Young Men, and Women Joseph Hellweg, Ph.D. CIRA 07/10/2002 12/30/2003 CIRA Pilot
44 Reducing HIV Risk in Methadone-Maintained Patients S. Kelly Avants, Ph.D. National Institute on Drug Abuse 01/20/1999 12/31/2003 R01
45 MIEL: Meditation and Massage in End of Life David L. Katz, M.D.,M.P.H National Institute of Nursing Research 09/30/2001 04/30/2004
46 AIDS International Training and Research Program Supplement to India Michael H. Merson, M.D. Fogarty International Center 10/01/1999 05/31/2004
47 HIV and Other Risks of the Transnational Commercial Sex Trade: Assessing Social and Cultural Factors CIRA 07/01/2003 06/30/2004
48 HIV/AIDS and the Disability: A Global Survey on HIV/AIDS on Disability Nora Ellen Groce, Ph.D. World Bank HIV/AIDS 01/15/2003 06/30/2004
49 Inclusion of HIV/AIDS Educational Messages in Traditional 'Rites of Passage' Nora Ellen Groce, Ph.D. CIRA 07/01/2003 06/30/2004
50 Minority Youth Action Research Training Institute Jean J. Schensul, Ph.D. National Institute of Mental Health 09/30/1998 06/30/2004
51 A Pilot HIV/AIDS Intervention for Crack Users in New Haven Kaveh Khoshnood, Ph.D., M.P.H. CIRA 09/01/2002 08/31/2004 CIRA Pilot
52 Microbicide Acceptance--Prevent HIV in High-Risk Women Margaret R. Weeks, Ph.D. National Institute of Mental Health 09/30/2000 08/31/2004 R01
53 Sociocultural Factors on Syringe Sharing and HIV Risks JiangHong Li, M.D., M.Sc. National Institute on Drug Abuse 09/30/2001 08/31/2004 R03
54 Research Ethics in Cross-Cultural HIV/AIDS Studies with Active Users of Illicit Drugs Kaveh Khoshnood, Ph.D., M.P.H. CIRA 10/01/2003 09/30/2004
55 The Role of Folk Remedies including Traditional Medicine for Sexually Transmitted Infection Treatment in Sub-Saharan Africa Linda Niccolai, Ph.D. CIRA 10/01/2003 09/30/2004
56 Increasing Drug Users' Adherence to HIV Therapeutics Robert S. Broadhead, Ph.D. National Institute on Drug Abuse 12/25/1999 11/30/2004
57 Drug Policy in the Islamic Republic of Iran Kaveh Khoshnood, Ph.D., M.P.H. Yale Center for International and Area Studies 07/01/2004 12/31/2004
58 Toll-Like Receptor Ligands as Microbicide for Sexually Transmitted Viruses Akiko Iwasaki, Ph.D. CIRA 02/09/2004 02/08/2005 CIRA Pilot
59 Structural and Policy Factors in Black-White Disparities in HIV/AIDS Michael H. Merson, M.D. Office of AIDS Research 09/01/2002 02/28/2005
60 Women's Sexual Behavior in the Context of Injection Drug Use Kim M. Blankenship, Ph.D. CIRA 06/30/1999 02/28/2005 CIRA Pilot
61 Role of Emotional Distress and Suicidality in HIV/AIDS-Related Risky Sexual Behavior During Adolescence Golan Shahar, Ph.D. CIRA 04/16/2003 04/15/2005 CIRA Pilot
62 Community Organizations in Syringe Exchange in Springfield, MA Susan Shaw, Ph.D. National Institute on Drug Abuse 06/01/2003 05/31/2005 R03
63 Community Organizations in Syringe Exchange in Springfield, MA National Institute on Drug Abuse 06/01/2003 05/31/2005 R03
64 Unmet Mental Health Care Needs of Patients in an HIV Specialty Clinic Lydia Chwastiak, M.D.,M.P.H CIRA 06/04/2004 06/03/2005 CIRA Pilot
65 Drinking Behaviors of Migrant and Non-Migrant Farmworkers Michael Duke, Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/28/2001 06/30/2005 R01
66 Physician Delivered Intervention with HIV+ Individuals National Institute of Mental Health 07/15/1999 06/30/2005
67 Improving Sexual Communication Between Parents and Their Deaf Teens: A Critical Gap in Needs Nora Ellen Groce, Ph.D. CIRA 09/28/2004 09/27/2005 CRPP
68 Improving Sexual Communication Between Parents and Their Deaf Teens: A Critical Gap in Needs CIRA 09/28/2004 09/27/2005 CRPP
69 Project TRUST: Directly Observed Anti-Retroviral Therapy Among Active Drug Users Frederick L Altice, M.D. National Institute on Drug Abuse 09/29/2000 09/28/2005 R01
70 Building Community Responses to Risks of Emergent Drug Use Centers for Disease Control 09/30/2002 09/29/2005
71 Development and Implementation of a Spiritual Coping Intervention for Individuals with HIV Nalini Tarakeshwar, Ph.D. CIRA 01/01/2003 12/31/2005 CIRA Pilot
72 Crack Use and Related Sexual Risk in El Salvador Julia Dickson-Gomez, Ph.D. CIRA 02/12/2003 02/11/2006 CIRA Pilot
73 HIV/AIDS and Disability in the Developing World: A Pilot Study in Swaziland Nora Ellen Groce, Ph.D. CIRA 02/12/2003 02/11/2006 CIRA Pilot
74 Zero Tolerance: The Impact of Eviction on Health and HIV-Related Risk Behaviors Sonja Plesset, Ph.D. CIRA 02/13/2004 02/12/2006 CIRA Pilot
75 An Analysis and Comparison of Cross-Border Populations Related to the HIV Epidemic in Three Regions of China Ann B. Williams, R.N.C., Ed.D. CIRA 03/15/2005 03/14/2006
76 Structural Interventions and Women's Risk for HIV: Is There Evidence of Lessons Learned from "Successful" Country HIV/AIDS Programs? Kari Hartwig, Dr. P.H., M.A. CIRA 10/12/2004 04/11/2006
77 Developing a Social Marketing Campaign for Urban At-Risk Youth Kari Hartwig, Dr. P.H., M.A. CIRA 05/13/2005 05/12/2006 CRPP
78 Developing a Social Marketing Campaign for Urban At-Risk Youth CIRA 05/13/2005 05/12/2006 CRPP
79 HIV Testing and Behavior Change Christopher Udry, Ph.D. CIRA 06/25/2004 06/24/2006 CIRA Pilot
80 A Community Based HIV/STI Intervention for Pregnant Women in Haiti Trace Kershaw, Ph.D. CIRA 06/01/2003 06/30/2006 CIRA Pilot
81 Acupuncture and Coping Skills Training for Cocaine Abuse Arthur Margolin, Ph.D. National Institute on Drug Abuse 09/15/2000 06/30/2006
82 The Impact of Health System Factors on HIV/AIDS Prevention and Treatment in Poor Rural China Hong Wang, Ph.D. CIRA 07/07/2005 07/06/2006 CIRA Pilot
83 HIV Prevention in High-Risk Drug Use Sites: Project RAP (Risk Avoidance Partnership) Margaret R. Weeks, Ph.D. National Institute on Drug Abuse 01/08/2000 07/19/2006 R01
84 HIV Transmission in Russia Through Liquid Drug Injection Robert Heimer, Ph.D. National Institute on Drug Abuse 09/30/2001 08/31/2006 R01
85 Internet-Based HIV Prevention Technology Transfer with World NGOs Jeffrey A. Kelly, Ph.D. National Institute of Mental Health 09/30/2001 08/31/2006
86 HIV Care and Treatment Collaborative Program in Russia Krystn Wagner, M.D., Ph.D. American International Health Alliance 07/01/2004 09/30/2006
87 Monitoring and Evaluation of an ARV Pilot Program in Tamil Nadu, India Michael H. Merson, M.D. Children's Investment Fund Foundation (India) 08/01/2004 10/31/2006
88 Guidelines for HIV/AIDS Interventions for People who are Deaf, Blind and Intellectually Disabled Nora Ellen Groce, Ph.D. World Health Organization 05/01/2006 12/31/2006
89 Raising the Voice of the African Decade of Disabled Persons Nora Ellen Groce, Ph.D. Rehabilitation International 01/01/2006 12/31/2006
90 Study of Research Ethics with Active Users of Illicit Drugs Kaveh Khoshnood, Ph.D., M.P.H. Donaghue Foundation 01/01/2004 12/31/2006
91 The Impact of HIV/AIDS on Disabled Populations: Policy Interventions Nora Ellen Groce, Ph.D. International Labor Organization 01/01/2006 12/31/2006
92 Syringe Exchange Based Hepatitis B Vaccination of IDUs Robert Heimer, Ph.D. National Institute on Drug Abuse 03/01/2003 02/28/2007 R01
93 Understanding the Social and Psychological Context of Acute Infection: Yale-Brown Collaboration Paul D. Cleary, Ph.D. National Institute of Mental Health 09/30/2001 02/28/2007
94 Administrative Supplement to TB-AIDS ICOHRTA Robert Heimer, Ph.D. Fogarty International Center/National Institute on Drug Abuse 04/01/2005 03/31/2007
95 Intervention to Reduce HIV/STD Risk in Teen Pregnancy Jeannette R. Ickovics, Ph.D. National Institute of Mental Health 04/24/2001 03/31/2007 R01
96 Microbicide/Female Condom Acceptability for Sex Workers in China Margaret R. Weeks, Ph.D. National Institute of Mental Health/Fogarty International Center 05/15/2003 04/30/2007 RO3
97 Adult, Aware, and Alive Lauretta Grau, Ph.D. CIRA 06/08/2006 06/07/2007 CRPP
98 Adult, Aware, and Alive CIRA 06/08/2006 06/07/2007 CRPP
99 Criminal Justice, Race, and HIV Risk in CT Drug Users Kim M. Blankenship, Ph.D. National Institute on Drug Abuse 09/25/2004 08/31/2007
100 Training in HIV Prevention & Care Research in South Africa-ICOHRTA Kari Hartwig, Dr. P.H., M.A. Fogarty International Center/National Institute on Drug Abuse 09/27/2001 09/30/2007
101 High Risk Crack Use Settings and HIV in El Salvador Julia Dickson-Gomez, Ph.D. National Institute on Drug Abuse 09/20/2006 10/22/2007
102 Project Parivartan: Structural Interventions and HIV Prevention among Sex Workers, their Clients, and Injection Drug Users in India Kim M. Blankenship, Ph.D. Bill and Melinda Gates Foundation 05/01/2004 12/31/2007
103 Project Parivartan: Structural Interventions and HIV Prevention among Sex Workers, their Clients, and Injection Drug Users in India Kim M. Blankenship, Ph.D. Bill and Melinda Gates Foundation 05/01/2004 12/31/2007
104 Sustained Safe Behavior in High-Risk Women Margaret R. Weeks, Ph.D. National Institute of Mental Health 02/06/2004 01/31/2008 R01
105 Pilot Intervention Research: Brief Care-based HIV Prevention for Newly Diagnosed Men Robert Heimer, Ph.D. Gilead Foundation 09/01/2006 02/29/2008
106 Access to ARV Therapy and Stigma: The Perceived Magnitude, Impact, and Implications of Stigma for HIV/AIDS Prevention Interventions among Women in Kenya Erica Dawson, Ph.D. CIRA 04/01/2006 03/31/2008 CIRA Pilot
107 Latinos Living with HIV/AIDS -- Access to Subacute Care Jean M. Breny, Ph.D., M.P.H. CIRA 04/05/2007 04/04/2008 CRPP
108 Latinos Living with HIV/AIDS -- Access to Subacute Care Martha Dale CIRA 04/05/2007 04/04/2008 CRPP
109 Longitudinal Study of the RAP Peer Intervention for HIV Margaret R. Weeks, Ph.D. National Institute on Drug Abuse 08/01/2000 04/30/2008 R01
110 Wise Women Win: Mentoring by and for Mature Women for HIV/STD Prevention Linda Niccolai, Ph.D. CIRA 05/02/2006 04/30/2008 CRPP
111 Wise Women Win: Mentoring by and for Mature Women for HIV/STD Prevention Nicholas Boshnack, M.S.W. CIRA 05/02/2006 04/30/2008 CRPP
112 Coping with Pediatric HIV/AIDS in South Africa: Needs Assessment and Development of a Child Focused Psychosocial Intervention CIRA 06/20/2006 06/19/2008 CIRA Pilot
113 Evaluating the Effects of Expanded Hours for Syringe Exchange Programs in Connecticut Robert Heimer, Ph.D. Gilead Foundation 09/01/2006 06/30/2008
114 Integrating Sex and Drug Related HIV Risk and Transmission (Diversity Supplement) Robert Heimer, Ph.D. National Institute on Drug Abuse 07/01/2005 06/30/2008 U01
115 Prevention with Newly HIV+ Men: A Pilot Intervention-Supplement to P30MH66294-05 Paul D. Cleary, Ph.D. Office of AIDS Research 09/15/2006 06/30/2008 P30
116 The Impact of Compliance with the WTO Trade Related Aspects of Intellectual Property (TRIPS) Agreement on Access to HIV/AIDS Medicines in India and Other Low and Middle Income Countries Amy Kapczynski, J.D. CIRA 07/19/2006 07/18/2008 CIRA Pilot
117 Identifying HIV-Bridge-Population in STI Clinics, Russia National Institute on Drug Abuse 09/25/2005 07/31/2008 R03
118 Participant Perspectives on Drug Use/HIV Research Ethics National Institute on Drug Abuse 09/20/2005 07/31/2008 R01
119 Risk Assessment of STDs Among IDUs in Russia CIRA 02/01/2001 07/31/2008 CIRA Pilot
120 Markers of Alcohol Toxicity in HIV-Infected Veterans National Institute on Alcohol Abuse and Alcoholism 09/30/2005 08/31/2008
121 Modeling HIV Subjects' Electronic Monitoring Data George Knafl, Ph.D. National Institute of Allergy and Infectious Disease 02/01/2004 10/31/2008 R01
122 Provision of HIV Care and Antiretroviral Therapy Through a Strengthened Community-Based Tuberculosis Directly Observed Therapy Program in Rural South Africa: The Sizon’qoba ("We Shall Overcome") Project Gerald H. Friedland, M.D. Doris Duke Foundation 11/05/2004 11/14/2008
123 Project BEST: Buprenorphine Treatment Expansion in HIV Clinical Settings Frederick L Altice, M.D. Center for Substance Abuse Treatment 12/01/2003 11/20/2008
124 Provision of Tuberculosis and Antiretroviral Therapy in Rural KwaZulu Natal Gerald H. Friedland, M.D. Irene Diamond Fund 10/01/2002 12/31/2008
125 Risk in Partnerships for Repeat Sexually Transmitted Infection Linda Niccolai, Ph.D. Donaghue Foundation 01/01/2005 12/31/2008
126 Combating MDR and SDR TB and HIV in Rural South Africa Gerald H. Friedland, M.D. Doris Duke Foundation 02/02/2007 02/22/2009
127 Substance Use and Other Situational Factors Impacting Sexual Risk-Taking among HIV-Positive Men who have Sex with Men (MSM) CIRA 02/18/2005 02/28/2009 CIRA Pilot
128 Expansion and Integration of TB/HIV Care and Treatment in Rural KwaZulu Natal, South Africa Gerald H. Friedland, M.D. President's Emergency Program for AIDS Relief (PEPFAR) 05/01/2007 04/30/2009
129 AIDS International Training and Research Program Supplement: SPSU PH Educational Program Fogarty International Center 09/30/1998 05/31/2009
130 Yale AITRP: Supplement for Nicaragua Fogarty International Center 09/22/2004 05/31/2009
131 Alcohol & HIV in Kenya: Stage 1 Trial of a Peer-led Alcohol Behavior Intervention Rebecca Papas, Ph.D. National Institute on Alcohol Abuse and Alcoholism 07/10/2007 06/30/2009 R21
132 China Multidisciplinary AIDS Prevention Training Program Kaveh Khoshnood, Ph.D., M.P.H. Fogarty International Center 07/01/2004 06/30/2009
133 Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence Lynn E. Fiellin, M.D. The Robert Wood Johnson Foundation 07/01/2006 06/30/2009
134 The Context of HIV Testing for Detection of Early HIV Infection in St. Petersburg Linda Niccolai, Ph.D. CIRA 10/01/2007 06/30/2009 CIRA Pilot
135 Supportive Housing for PLHA: Risk Behaviors and Prevention Interventions Kim M. Blankenship, Ph.D. CIRA 07/17/2007 07/16/2009 CRPP
136 Supportive Housing for PLHA: Risk Behaviors and Prevention Interventions Shawn Lang, B.A. CIRA 07/17/2007 07/16/2009 CRPP
137 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment (Diversity supplement) Trace Kershaw, Ph.D. National Institute of Mental Health 08/14/2008 07/31/2009
138 Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care Setting David A. Fiellin, M.D. Health Resources and Services Administration 09/01/2004 08/31/2009
139 HIV Prevention Research with HIV+ Incarcerated Populations Frederick L Altice, M.D. National Center for HIV, Viral Hepatitis, STDs and TB Prevention 09/01/2006 08/31/2009 UR6
140 Integrating Buprenorphine into HIV Clinical Care Settings Frederick L Altice, M.D. Health Resources and Services Administration 09/01/2006 08/31/2009
141 NIMH Collaborative HIV/STD Prevention Trial (Russia) Jeffrey A. Kelly, Ph.D. National Institute of Mental Health 09/30/1999 08/31/2009 U10
142 Improving Health Outcomes for Released HIV+ Prisoners Frederick L Altice, M.D. National Institute on Drug Abuse 04/20/2006 03/31/2010 R21
143 Administrative Supplement to Establish an NIH/FIC Alumni Association in Russia Fogarty International Center/ National Institute of Environmental Health Sciences 09/30/1998 05/31/2010 D43 Supplement
144 Research Training in HIV-Associated Cancer Genomics Fogarty International Center 10/01/2007 05/31/2010 D43
145 Developing a Scientific and Methodological Center for Research and Facilitation Efficiency Improvement of Organizations Engaged in HIV Prevention in the Russian Federation Robert Heimer, Ph.D. U.S. Civilian Research and Development Foundation 06/15/2008 06/30/2010
146 Directly Observed Therapy for Community-Released HIV+Prisoners Frederick L Altice, M.D. National Institute on Drug Abuse 09/01/2004 06/30/2010 R01
147 What They're Not Telling Me: Veterans, Trust, and HIV Care in the VA amfAR 08/01/2008 08/01/2010
148 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment & Transition (Summer Supplement) Trace Kershaw, Ph.D. National Institute of Mental Health 06/01/2009 09/30/2010
149 Project Parivartan: Structural Interventions and HIV Prevention among Sex Workers and their Clients in India (supplement) Kim M. Blankenship, Ph.D. Bill and Melinda Gates Foundation 07/01/2007 12/31/2010
150 The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment David A. Fiellin, M.D. CIRA 08/23/2007 12/31/2010 CIRA Pilot
151 Population Size, Characteristics & HIV Risks among Transgender People in Hartford Margaret R. Weeks, Ph.D. CIRA 01/06/2010 01/05/2011 CRPP
152 Population Size, Characteristics & HIV Risks among Transgender People in Hartford CIRA 01/06/2010 01/05/2011 CRPP
153 Population Size, Characteristics & HIV Risks among Transgender People in Hartford Jerimarie Liesegang, Ph.D. CIRA 01/06/2010 01/05/2011 CRPP
154 Addressing HIV Risk in Young Unhealthy Alcohol Drinkers in the Emergency Department with Rapid HIV Testing and Brief Intervention Lynn E. Fiellin, M.D. CIRA 09/21/2009 06/30/2011 CIRA Pilot
155 CIRA/St. Petersburg Research Collaborative Project Robert Heimer, Ph.D. CIRA 03/03/2011 06/30/2011 CIRA Pilot
156 CIRA/University of Pretoria South Africa Research Collaboration Project CIRA 03/14/2011 06/30/2011 CIRA Pilot
157 Environmental Factors in HIV Transmission among Suburban IDUs (Diversity Supplement) Robert Heimer, Ph.D. National Institute on Drug Abuse 07/01/2009 06/30/2011 R01 Supplement
158 Food Insecurity and HIV Prevention and Risk Reduction among Individuals Recently Released from Prison CIRA 12/01/2009 06/30/2011 CIRA Pilot
159 Counseling for Primary Care Office-Based Buprenorphine David A. Fiellin, M.D. National Institute on Drug Abuse 08/20/2005 07/31/2011 R01
160 Opioids & HIV Medications: Interactions in Drug Abusers Gerald H. Friedland, M.D. National Institute on Drug Abuse 04/20/1999 07/31/2011 R01
161 Off-Site Sexually Transmitted Infection Testing for Connecticut Men Who Have Sex with Men CIRA 08/13/2010 08/12/2011 CRPP
162 Off-Site Sexually Transmitted Infection Testing for Connecticut Men Who Have Sex with Men Christopher Cole, B.S. CIRA 08/13/2010 08/12/2011 CRPP
163 International Feasibility Study of Pharmacy-Based HIV Prevention: St. Petersburg Robert Heimer, Ph.D. National Institute on Drug Abuse 09/15/2009 08/31/2011 R21
164 Potential for HIV Transmission in Relationships of Drug-using Women in Russia Linda Niccolai, Ph.D. National Institute on Drug Abuse 09/01/2008 08/31/2011 R21
165 Identifying Adolescents at Risk for Transitioning into Injection Drug Use in Russian Cities: Preliminary Research Nathan Hansen, Ph.D. CIRA 09/10/2010 09/09/2011 CIRA Pilot
166 Facilitators and Barriers to Addressing Intimate Partner Violence in CT HIV/AIDS Services Agencies Nathan Hansen, Ph.D. CIRA 12/06/2010 12/05/2011 CRPP
167 Facilitators and Barriers to Addressing Intimate Partner Violence in CT HIV/AIDS Services Agencies Shawn Lang, B.A. CIRA 12/06/2010 12/05/2011 CRPP
168 Confronting XDR TB and HIV in Rural South Africa Gerald H. Friedland, M.D. Gilead Foundation 01/01/2008 12/31/2011
169 Promoting Resilience in Young Children of HIV-infected Mothers in South Africa National Institute of Mental Health 09/30/2005 12/31/2011 R01
170 Evaluation of Opt-Out HIV Screening in a Family Planning Setting CIRA 03/17/2011 03/16/2012 CRPP
171 Evaluation of Opt-Out HIV Screening in a Family Planning Setting Linda Niccolai, Ph.D. CIRA 03/17/2011 03/16/2012 CRPP
172 Environmental Factors in HIV Transmission among Suburban IDUs Robert Heimer, Ph.D. National Institute on Drug Abuse 07/01/2007 04/30/2012 R01
173 The Influence of Peer Social Networks on Sexual Risk and Service Utilization among Young Fathers Trace Kershaw, Ph.D. CIRA 06/27/2011 06/26/2012 CRPP
174 The Influence of Peer Social Networks on Sexual Risk and Service Utilization among Young Fathers CIRA 06/27/2011 06/26/2012 CRPP
175 National AIDS Prevention Research Centers Proposed Multi-Level Intervention Planning Workshops Paul D. Cleary, Ph.D. Office of AIDS Research 01/01/2010 06/30/2012
176 Project C.O.A.C.H.: Counseling Others About Contacts and Exposures with HIV Eva Jennifer Edelman, M.D. Robert Wood Johnson Foundation 07/01/2011 06/30/2012
177 Addressing Adherence to PMTCT and Early Care of Women and Infants in South Africa National Institute of Mental Health 08/05/2009 07/31/2012 R21
178 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment & Transition Trace Kershaw, Ph.D. National Institute of Mental Health 09/22/2006 07/31/2012 R01
179 Evaluating the Link between HIV Prevention and Treatment National Institute of Mental Health 07/01/2002 08/31/2012 R01
180 Alcohol Associated Outcomes among HIV+/- Aging Veterans Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2006 08/31/2012 U10
181 Risk patterns of Latino/a Emergent Adult Sexual Networks CIRA 09/15/2011 09/14/2012 CRPP
182 Risk patterns of Latino/a Emergent Adult Sexual Networks Cándida Flores CIRA 09/15/2011 09/14/2012 CRPP
183 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment and Transition (2nd Diversity Supplement) Trace Kershaw, Ph.D. National Institute of Mental Health 06/01/2009 09/30/2012
184 Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregnant Women National Institute on Drug Abuse 01/15/2009 12/31/2012 R01
185 Integrating HIV Prevention into Clinical Care for PLWHA in South Africa National Institute of Mental Health 01/01/2007 12/31/2012 R01
186 High-Risk Establishments and Women's HIV Prevention in Southern China Margaret R. Weeks, Ph.D. National Institute of Mental Health 02/01/2007 01/31/2013 R01
187 Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study Jeannette R. Ickovics, Ph.D. National Institute of Mental Health 08/18/2006 01/31/2013 R01
188 Injection Drug Use within the Family Context: Damage Limitation, Qualification, and Acceptance Lauretta Grau, Ph.D. CIRA 02/01/2012 01/31/2013 Pilot Project
189 A Computer Simulation of the Sub-Saharan HIV Pandemic Scott Braithwaite, M.D., M.Sc. National Institute on Alcohol Abuse and Alcoholism 09/30/2007 02/28/2013 R01
190 Identifying Culturally Appropriate Peer-based Interventions for Monolingual Spanish Speaking and Bilingual Hispanic Women with HIV, Substance Abuse, and Intimate Partner Violence: Preliminary Research Cristina Cruza-Guet, Ph.D. CIRA 03/26/2012 03/25/2013 Pilot Project
191 A Randomized Trial of Enhanced Nursing Telephone Support to Improve Medication Self-Management and Viral Outcomes of Antiretroviral Therapy-Experienced Patients Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Allergy and Infectious Disease 06/29/2006 05/31/2013
192 Reduction of Gender-Based Violence in Rural Cote d’Ivoire The World Bank 09/01/2010 05/31/2013
193 Alcohol and HIV Risk Reduction in St. Petersburg, Russian Federation National Institute on Alcohol Abuse and Alcoholism 09/30/2007 06/30/2013 R01
194 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
195 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
196 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
197 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
198 Neighborhood Impact on HIV, Drug Abuse, and Criminal Justice Outcome Frederick L Altice, M.D. CIRA 03/01/2013 06/30/2013 Pilot Project
199 Neighborhood Impact on HIV, Drug Abuse, and Criminal Justice Outcome Debarchana (Debs) Ghosh, Ph.D. CIRA 03/01/2013 06/30/2013 Pilot Project
200 Utilizing Social Technologies and Social Networks to Increase HIV Testing among Men Who Have Sex with Men in Connecticut Trace Kershaw, Ph.D. CIRA 08/28/2012 08/27/2013 CIRA Pilot Project
201 Project TRANSITIONS: Enhancing Linkages to HIV Primary Care in Jail Settings Frederick L Altice, M.D. Health Resources and Services Administration 09/01/2007 08/31/2013
202 Randomized Controlled Trial to Enhance Dual Protection among PLHIV in India Trace Kershaw, Ph.D. National Institute of Child Health and Human Development 09/10/2009 08/31/2013 R01
203 Translation of the Risk Avoidance Partnership (RAP) for Drug Treatment Clinic Implementation Margaret R. Weeks, Ph.D. National Institute on Drug Abuse 09/15/2010 08/31/2013 R34
204 Project CHOICES: Targeted Capacity Expansion Program for Substance Abuse Treatment and HIV/AIDS Frederick L Altice, M.D. Center for Substance Abuse Treatment 09/30/2008 09/29/2013
205 Assessing and Addressing Stigma towards PLWHA in Connecticut to Strengthen the Implementation of Evidence-Based Interventions Valerie Earnshaw, Ph.D. CIRA 10/16/2012 10/15/2013 Pilot Project
206 Assessing and Addressing Stigma towards PLWHA in Connecticut to Strengthen the Implementation of Evidence-Based Interventions Shawn Lang, B.A. CIRA 10/16/2012 10/15/2013 Pilot Project
207 Enhancing HIV Prevention through a Multi-level Community Intervention to Promote Women-Initiated Prevention Options Margaret R. Weeks, Ph.D. National Institute of Mental Health 01/15/2009 12/31/2013 R01
208 Online Respondent-Driven Sampling & Data Collection Edward White, Ph.D. National Institute of Mental Health 01/01/2011 12/31/2013 R21
209 The Effects of HIV Disease in Pregnancy on the Development of Uninfected Children: an Exploratory Study to Understand Possible Mechanisms Albert McKern Trust Fund 02/15/2012 02/15/2014
210 IDU Peer Recruitment Dynamics and Network Structure in Respondent Driven Sampling JiangHong Li, M.D., M.Sc. National Institute on Drug Abuse 03/15/2011 02/28/2014 R01
211 Impacts of Individual and Social Behavior on Influenza Dynamics and Control National Institute of General Medical Sciences 06/01/2009 04/30/2014 U01
212 Intervention to Reduce Acute Stress and HIV Risk in Newly HIV Diagnosed Men Trace Kershaw, Ph.D. National Institute of Mental Health 06/21/2010 05/31/2014 R34
213 A Couple-based Relationship Strengthening HIV Intervention for Young Parents Trace Kershaw, Ph.D. National Institute of Mental Health 07/16/2011 06/30/2014 R34
214 Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS (SHARPP II) Kim M. Blankenship, Ph.D. National Institute on Drug Abuse 09/15/2009 07/31/2014 R01
215 Alcohol Pharmacotherapies Among Released Prisoners Frederick L Altice, M.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2009 08/31/2014 R01
216 Alcohol Pharmacotherapies Among Released Prisoners Sandra Springer, M.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2009 08/31/2014 R01
217 Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia Richard S Schottenfeld, M.D. National Institute on Drug Abuse 09/30/2001 08/31/2014 R01
218 Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention Lynn E. Fiellin, M.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2009 08/31/2014 R01
219 Evaluating Violence against Women Screening in Mexico City Anonymous 01/01/2012 12/31/2014
220 Multidisciplinary HIV and TB Implementation Sciences Training in China Kaveh Khoshnood, Ph.D., M.P.H. Fogarty International Center 07/01/2009 03/31/2015 U2R
221 With an Eye to the Law: Providing Client-Centered Care in the Shadow of Criminal Prosecution for HIV Exposure Robert Wood Johnson Foundation 04/01/2013 03/31/2015
222 With an Eye to the Law: Providing Client-Centered Care in the Shadow of Criminal Prosecution for HIV Exposure Robert Wood Johnson Foundation 04/01/2013 03/31/2015
223 Chronic Opioid Therapy and Patient Safety in HIV Infected and Uninfected Veterans Julie R. Gaither, R.N., M.P.H. National Institute on Drug Abuse 04/01/2013 03/31/2015 F31
224 Using Cell Phones to Understand Social Networks of Young Men Trace Kershaw, Ph.D. National Institute on Drug Abuse 06/01/2012 05/31/2015 R21
225 Liver cancer risk and prevention among persons living with HIV/AIDS Lesley Park, Ph.D., M.P.H. National Cancer Institute 09/01/2013 06/29/2015 F31
226 Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Frederick L Altice, M.D. National Institute on Drug Abuse 09/30/2008 06/30/2015 R01
227 Characterizing the Post-incarceration Risk Environment in St. Petersburg, Russia Javier Cepeda, M.P.H., Ph.D. National Institute on Drug Abuse 09/01/2013 06/30/2015 F31
228 HIV Prevention Needs Among MSM in Small Urban Areas Danya Keene, Ph.D. NIMH through CIRA's Pilot Project Program 06/09/2014 06/30/2015
229 HIV Prevention Needs Among MSM in Small Urban Areas John Pachankis, Ph.D. NIMH through CIRA's Pilot Project Program 06/09/2014 06/30/2015
230 Barriers to Implementation of Isoniazid Prevention Therapy in Rural KwaZulu-Natal, South Africa Sheela V. Shenoi, M.D.,M.P.H NIMH through CIRA's Pilot Project Program 06/09/2014 06/30/2015
231 Implementing Point of Care CD4 Analysis to Decentralize HIV Care in Rural Africa Gerald H. Friedland, M.D. National Institute of Allergy and Infectious Diseases 08/01/2012 07/31/2015 R21
232 Implementing Point of Care CD4 Analysis to Decentralize HIV Care in Rural Africa Sheela V. Shenoi, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 08/01/2012 07/31/2015 R21
233 Enhancing Health Outcomes with HIV+ Substance Abusers Frederick L Altice, M.D. National Institute on Drug Abuse 09/01/2008 07/31/2015 K24
234 Community-based HIV Education Research Program for Diverse Scholars Trace Kershaw, Ph.D. National Institute of Mental Health 09/01/2010 08/31/2015 R25
235 Community-based HIV Education Research Program for Diverse Scholars Barbara Guthrie, Ph.D., R.N., FAAN National Institute of Mental Health 09/01/2010 08/31/2015 R25
236 Community-based HIV Education Research Program for Diverse Scholars Jean J. Schensul, Ph.D. National Institute of Mental Health 09/01/2010 08/31/2015 R25
237 Overweight/Obesity and Weight Gain among HIV-Positive Prisoners in Rhode Island: Prevalence and Intervention Feasibility Amy Smoyer, Ph.D. NIMH through CIRA's Pilot Project Program 10/03/2014 10/02/2015 Pilot Project
238 Disparities in HPV Vaccine Completion: Identifying and Quantifying the Barriers Linda Niccolai, Ph.D. National Cancer Institute 12/01/2012 11/30/2015 R21
239 Estimating the Size of Hidden and Hard-to-Reach Populations using Respondent-driven Sampling Forrest W. Crawford, Ph.D. NIMH through CIRA's Pilot Project Program 02/20/2015 02/19/2016
240 HIV Prevention Needs Among Unstably Housed Youth in Small Urban Areas Heather Mosher, Ph.D. NIMH through CIRA's Pilot Project Program 04/27/2015 04/26/2016 Pilot Project
241 Serosorting Intervention for HIV Negative MSM National Institute of Mental Health 07/11/2011 04/30/2016 R01
242 Community-based Intensive Case Finding for HIV, TB, and MDR/XDR TB in Rural South Africa Sheela V. Shenoi, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 05/15/2011 04/30/2016 K23
243 Self- and Family-Management Intervention in HIV+ Chinese Women Wei-Ti Chen, Ph.D. National Institute of Nursing Research 05/16/2013 04/30/2016 K23
244 Intervention Development for Social Stress, Mental Health, and HIV Risk among MSM John Pachankis, Ph.D. National Institute of Mental Health 07/01/2012 04/30/2016 R34
245 Building Mobile Health HIV-Prevention Capacity for MSM in Romania John Pachankis, Ph.D. Fogarty International Center 09/10/2014 04/30/2016 R21
246 Developing a Comprehensive Model of the HIV Care Continuum in Nine Small Cities in Connecticut, Massachusetts, and Rhode Island Lauretta Grau, Ph.D. National Institute of Mental Health 07/01/2015 04/30/2016 CIRA Pilot Project
247 Developing a Comprehensive Model of the HIV Care Continuum in Nine Small Cities in Connecticut, Massachusetts, and Rhode Island Thomas J. Stopka, Ph.D., M.H.S. National Institute of Mental Health 07/01/2015 04/30/2016 CIRA Pilot Project
248 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven Philip A. Chan, M.D. National Institute of Mental Health 04/24/2015 04/30/2016
249 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven Eva Jennifer Edelman, M.D. National Institute of Mental Health 04/24/2015 04/30/2016
250 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven National Institute of Mental Health 04/24/2015 04/30/2016
251 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven Onyema Ogbuagu, M.D. National Institute of Mental Health 04/24/2015 04/30/2016
252 HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM National Institute on Drug Abuse 07/15/2011 04/30/2016 RO1
253 Racial/ethnic Differences in Daily Dynamics of PTSD, Sexual-Risk & Substance Use Tami P. Sullivan, Ph.D. National Institute on Drug Abuse 07/15/2011 05/31/2016 R01
254 The Impact of Incarceration and Substance Abuse on HIV-Infected Veterans National Institute on Drug Abuse 06/01/2012 05/31/2016 R03
255 HIV, Buprenorphine, and the Criminal Justice System Frederick L Altice, M.D. National Institute on Drug Abuse 09/30/2010 06/30/2016 R01
256 Reducing Violence and HIV Risk among War-Exposed Liberian Youth Nathan Hansen, Ph.D. National Institute of Mental Health 07/13/2011 06/30/2016 R34
257 Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in Vitro Robert Heimer, Ph.D. National Institute on Drug Abuse 09/01/2011 06/30/2016 R01
258 Medication Assisted Therapy as a Conduit to Care for HIV+ CJS Populations Transit Sandra Springer, M.D. National Institute on Drug Abuse 07/01/2011 06/30/2016 K02
259 An Interactive Video Game for HIV Prevention in At-Risk Adolescents Lynn E. Fiellin, M.D. National Institute of Child Health and Human Development 08/10/2009 07/31/2016 R01
260 Influences on HIV Prevalence and Service Access among IDUs in Russia and Estonia Robert Heimer, Ph.D. National Institute on Drug Abuse 09/01/2010 07/31/2016 R01
261 Influences on HIV Prevalence and Service Access among IDUs in Russia and Estonia National Institute on Drug Abuse 09/01/2010 07/31/2016 R01
262 Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for Women Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Allergy and Infectious Disease 09/25/2013 07/31/2016 R21
263 Naltrexone for Opiod Dependent Released HIV+ Criminal Justice Populations Sandra Springer, M.D. National Institute on Drug Abuse 09/30/2010 08/31/2016 R01
264 Alcohol and Multisubstance Use in the Veterans Aging Cohort Study Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/10/2011 08/31/2016 U01
265 Integrated Stepped Care for Unhealthy Alcohol Use in HIV David A. Fiellin, M.D. National Institute on Alcohol Abuse and Alcoholism 09/15/2011 08/31/2016 U01
266 Avoiding Delay in ART Initiation in Rural South Africa Sheela V. Shenoi, M.D.,M.P.H Patterson Foundation 04/01/2014 09/30/2016
267 Integration of TB and HIV in Community Settings Gerald H. Friedland, M.D. Health Systems Trust 10/01/2015 09/30/2016
268 Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda Sunil Parikh, M.D.,M.P.H NICHD/NIAID 12/23/2010 11/30/2016 R01
269 Using EMA to Assess the PTSD-HIV Risk Behavior Relationship in OEF/OIF Veterans National Institute on Drug Abuse 02/15/2015 01/31/2017 R21
270 Using the VACS Index to Track Health Outcomes Associated with Changes in Drug Use David A. Fiellin, M.D. NIDA 04/01/2013 02/28/2017 R01
271 Using the VACS Index to Track Health Outcomes Associated with Changes in Drug Use Amy C. Justice, M.D., M.Sc., Ph.D. NIDA 04/01/2013 02/28/2017 R01
272 Efficacy Trial of a Brief Health Enhancement Intervention for Newly Diagnosed Men Nathan Hansen, Ph.D. National Institute of Mental Health 04/01/2012 03/31/2017 R01
273 Efficacy Trial of a Brief Health Enhancement Intervention for Newly Diagnosed Men National Institute of Mental Health 04/01/2012 03/31/2017 R01
274 Social Determinants of HIV: The Intersecting Impacts of Mass Incarceration, Housing Stability, and Subsidized Housing Policies Kim M. Blankenship, Ph.D. National Institute of Mental Health 06/15/2016 03/31/2017 RO1
275 Social Determinants of HIV: The Intersecting Impacts of Mass Incarceration, Housing Stability, and Subsidized Housing Policies Linda Niccolai, Ph.D. National Institute of Mental Health 06/15/2016 03/31/2017 RO1
276 Training and Research in HIV Prevention in Russia Robert Heimer, Ph.D. Fogarty International Center 09/30/1998 04/30/2017 D43
277 Intervention to encourage HIV Testing and Counseling among Adolescents Lynn E. Fiellin, M.D. NICHD 05/01/2016 04/30/2017 R41
278 Test and Linkage to Care (TLC-IDU) Kenya Ann Kurth, Ph.D., CNM, MPH, FAAN National Institute on Drug Abuse 01/01/2016 04/30/2017 R01
279 Feasibility of a Multi-Sector Collaboration to initiate PrEP Uptake among IPV-Exposed Women Trace Kershaw, Ph.D. National Institute of Mental Health 05/17/2016 05/16/2017 CIRA Pilot Project
280 Research Ethics Training and Curriculum Development Program with China Kaveh Khoshnood, Ph.D., M.P.H. Fogarty International Center 06/01/2011 05/31/2017 R25
281 PrEP for HIV Prevention in MSM: Mixed-Methods Study of Behavior & Message Framing National Institute of Mental Health 06/01/2011 05/31/2017 K01
282 Working with HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (What If?) David A. Fiellin, M.D. National Institute on Drug Abuse 09/30/2015 05/31/2017 R01
283 Implementing PrEP in a Family Planning Setting Sarah K. Calabrese, Ph.D. National Institute of Mental Health 06/14/2016 06/13/2017 CIRA Pilot Project
284 Evaluating and Improving HIV Outcomes in Community-Based Women who Interface with the Criminal Justice System Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute on Drug Abuse 07/01/2012 06/30/2017 K23
285 A bioecological pediatric HIV disclosure intervention in Ghana - "SANKOFA" Elijah Paintsil, M.D. National Institute of Child Health & Human Development 09/01/2012 06/30/2017 R01
286 A bioecological pediatric HIV disclosure intervention in Ghana - "SANKOFA" Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Child Health & Human Development 09/01/2012 06/30/2017 R01
287 Care Corrections: Technology for Jail HIV/HCV Testing, Linkage and Care (TLC) Curt G. Beckwith, M.D. National Institute on Drug Abuse 09/30/2010 06/30/2017 R01
288 Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons Michael J. Silverberg, Ph.D., M.P.H. National Cancer Institute 09/14/2012 06/30/2017 RO1
289 International Clinical Research Fellowship Gerald H. Friedland, M.D. Doris Duke Charitable Foundation 07/01/2012 06/30/2017
290 Improving Isoniazid Prevention Therapy (IPT) Penetration through Intensification of Case Finding at the Community Level in Rural South Africa Anthony Moll Center for Global Health 08/01/2012 07/31/2017 U01
291 mHEALTH: Medical Home Engagement and Aligning Lifestyles and Transition from Homelessness Frederick L Altice, M.D. Health Resources and Services Administration 09/01/2012 08/31/2017 Special Project of National Significance (SPNS) grant
292 MIDAS Center for Communicable Disease Dynamics National Institute of General Medical Sciences 09/15/2009 08/31/2017 U54
293 Confronting XDR TB and HIV in Rural South Africa (2nd) Gerald H. Friedland, M.D. Irene Diamond Fund 07/01/2008 12/31/2017
294 Making Better Decisions: Policy Modeling for AIDS and Drug Abuse National Institute on Drug Abuse 09/25/2002 01/31/2018 R01
295 Safety and Comparative Effectiveness of New Medications for Unhealthy Alcohol Use in HIV David A. Fiellin, M.D. National Institute on Alcohol Abuse and Alcoholism 02/15/2015 01/31/2018 R01
296 Examining Multilevel System Dynamics Affecting HIV Community Viral Load Margaret R. Weeks, Ph.D. National Institute of Mental Health 03/23/2015 01/31/2018 R01
297 International Research Training on TB and Other Pulmonary Complications of HIV Luke Davis, M.D. Fogarty International Center 08/01/2013 01/31/2018 D43
298 Improving HIV and Substance Use Disorder Treatment Research by Integrating Randomized and Nonrandomized Studies: An Evaluation of Methadone for HIV-infected Opioid-dependent Malaysian Prisoners Alexander Bazazi, M.D., Ph.D. National Institute on Drug Abuse 03/16/2015 03/15/2018 F30
299 Modeling HCV/HIV Transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs Frederick L Altice, M.D. National Institute on Drug Abuse 04/01/2016 03/31/2018 R21
300 Expanding Medication Assisted Therapies in Ukraine Frederick L Altice, M.D. National Institute on Drug Abuse 04/15/2012 03/31/2018 RO1
301 Intervention To Promote PrEP Awareness and Equitable Prescription Among Providerss Sarah K. Calabrese, Ph.D. NIMH 05/01/2014 04/30/2018 K01
302 Mobile Health for Implementation of Home-Based TB Contact Investigation in Uganda Luke Davis, M.D. National Institute of Allergy and Infectious Diseases 06/17/2013 05/31/2018 R01
303 Evaluating Health and Economic Effects of Targeted Strategies in TB/HIV Epidemics Ted Cohen, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 07/01/2014 06/30/2018 RO1
304 Participatory System Dynamics Modeling to Simulate HIV Test-and Treat Improvements Margaret R. Weeks, Ph.D. National Institute of Mental Health 07/15/2016 06/30/2018 R21
305 New Methods for the Design and Evaluation of Large HIV Prevention nterventions Donna Spiegelman, Sc.D. National Institute of Allergy and Infectious Diseases 06/01/2014 06/30/2018 R01
306 Understanding Black Women's Experiences of Sexual Satisfaction to Inform HIV Prevention Jasmine Abrams, Ph.D. National Institute of Mental Health 07/11/2017 07/10/2018 REIDS Pilot Project
307 Culturally Enhanced Trauma Treatment for African American Youth: Integrating Racial Socialization Isha Metzger, Ph.D. National Institute of Mental Health 07/11/2017 07/10/2018 REIDS Pilot Project
308 HIV Oral Testing Infographic Experiment (HOTIE) S Raquel Ramos, FNP-BC MBA MSN PhD National Institute of Mental Health 07/11/2017 07/10/2018 REIDS Pilot Project
309 Who's On Board: Parent, Child, and Provider Attitudes towards the Feasibility of PrEP Uptake among Adolescents National Institute of Mental Health 07/31/2017 07/12/2018 CIRA Pilot Project
310 Who's On Board: Parent, Child, and Provider Attitudes towards the Feasibility of PrEP Uptake among Adolescents Tashuna Albritton, Ph.D. National Institute of Mental Health 07/31/2017 07/12/2018 CIRA Pilot Project
311 Improving Antiretroviral Adherence and Persistence Using MHealth Tools in HIV-Infected Cocaine Users Frederick L Altice, M.D. National Institute on Drug Abuse 08/01/2016 07/31/2018 R21
312 Integrating HIV and Depression Self Care to Improve Adherence in Perinatal Women Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Mental Health 08/15/2014 07/31/2018 R21
313 Intervention to Overcome Mental Health Disparities in Criminally-Justice Involved Transgender Women Jaclyn White Hughto, M.P.H. National Institute on Minority Health and Health Disparities 09/01/2016 08/31/2018 F31
314 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Trace Kershaw, Ph.D. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
315 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Philip A. Chan, M.D. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
316 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Jacob van den Berg, Ph.D, M.S. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
317 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Eva Jennifer Edelman, M.D. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
318 Promoting Mental and Sexual Health among Young Pregnant Women in Liberia Tamora Callands, Ph.D. Fogarty International Center 09/20/2013 12/31/2018 K01
319 Assessing Local HIV Care Continuum Experiences in Small Cities Lauretta Grau, Ph.D. National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
320 Assessing Local HIV Care Continuum Experiences in Small Cities Thomas J. Stopka, Ph.D., M.H.S. National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
321 Barriers to HIV Care for Adults 50yo+, a Neglected but at-risk Population in Ukraine Sheela V. Shenoi, M.D.,M.P.H National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
322 Barriers to HIV Care for Adults 50yo+, a Neglected but at-risk Population in Ukraine Julia Rozanova, Ph.D. National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
323 Adapting an evidence-based intervention for stigma-related stress, mental health, and HIV risk for MSM of color in small urban areas John Pachankis, Ph.D. National Institute of Mental Health 02/12/2018 02/11/2019 CIRA Pilot Project
324 Adapting an evidence-based intervention for stigma-related stress, mental health, and HIV risk for MSM of color in small urban areas Krystn Wagner, M.D., Ph.D. National Institute of Mental Health 02/12/2018 02/11/2019 CIRA Pilot Project
325 Development and Preliminary Trial of a Brief, Portable Health Intervention for Rural Sexual Minority Emerging Adults John Pachankis, Ph.D. National Institute of Mental Health 03/15/2017 02/28/2019 R21
326 Addressing Disparities in HIV Testing and Care among Displaced MSM Robert Heimer, Ph.D. National Institute of Child Health and Human Development 06/22/2017 03/31/2019 R21
327 The Impact of Incarceration On the Continuity of HIV Care in Connecticut National Institute on Drug Abuse 04/16/2016 04/15/2019 F30
328 Non-Medical Use of Prescription Opioids Among HIV-Infected Individuals: Trajectories and Impact On Health Outcomes Eva Jennifer Edelman, M.D. National Institute on Drug Abuse 08/01/2016 04/30/2019 R01
329 Understanding Self and Family Management in HIV-Positive Asian Americans in New York Wei-Ti Chen, Ph.D. National Institute on Minority Health and Health Disparities 08/15/2017 04/30/2019 R03
330 Pre-exposure prophylaxis, medical mistrust, stigma, and medication beliefs among a diverse sample of young adult men Jessica Jaiswal, Ph.D., M.P.H. National Institute of Mental Health 05/31/2018 05/30/2019 REIDS Pilot Project
331 Modeling HIV & Substance Abuse: Correcting Sampling Bias and Cost Effectiveness Alexei Zelenev, Ph.D. National Institute on Drug Abuse 06/15/2014 05/31/2019 K01
332 Interdisciplinary HIV Prevention Training Program Trace Kershaw, Ph.D. National Institute of Mental Health 07/01/1999 06/30/2019 T32
333 Training in Drug Abuse & HIV Prevention for Female & Transgender Sex Workers Jeffrey A. Wickersham, Ph.D. National Institute on Drug Abuse 07/01/2014 06/30/2019 K01
334 Connecting People, Places & Things: The Effect of these Connections on Adherence and Retention in HIV Care Interventions among HIV-infected Drug Users Debarchana (Debs) Ghosh, Ph.D. National Institute on Drug Abuse 08/01/2014 07/31/2019 K01
335 Prisons, Drug Injection and the HIV Risk Environment Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute on Drug Abuse 08/01/2017 07/31/2019 R21
336 Increasing Provider Competence for Treating Stress-related Mental Health Conditions in Low Resource Settings Corina Lelutiu-Weinberger, Ph.D. National Institute of Mental Health 08/01/2017 07/31/2019 R21
337 Increasing Provider Competence for Treating Stress-related Mental Health Conditions in Low Resource Settings John Pachankis, Ph.D. National Institute of Mental Health 08/01/2017 07/31/2019 R21
338 Comprehensive Translational Science Analytics Tools for the Global Health Agenda Donna Spiegelman, Sc.D. National Institute of Environmental Health Sciences 09/15/2018 07/31/2019 DP1
339 Project S.T.E.P. (Sex Talk to Empower Parents): Parents as HIV/STI Prevention Agents for Gay, Bisexual, and Queer Adolescents Through Comprehensive Parent-Child Sex Communication Dalmacio Dennis Flores, PhD, ACRN National Institute of Mental Health 08/02/2018 08/01/2019 REIDS Pilot Project
340 Multilevel determinants of HIV and STI testing among transmasculine individuals of color Madina Agénor, Sc.D., M.P.H. National Institute of Mental Health 08/03/2018 08/02/2019 REIDS Pilot Project
341 Project CONNECT Centers for Disease Control 09/01/2014 08/31/2019 U01
342 Project CONNECT Merceditas Villanueva, M.D. Centers for Disease Control 09/01/2014 08/31/2019 U01
343 Consortium to Improve Outcomes in HIV/AIDS, Alcohol, Aging and Multi-Substance Use (COMpAAAS) Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/01/2016 08/31/2019 U01
344 She's PrEPared: The Impact of Intimate Partner Violence on Women's Engagement in the PrEP Care Continuum Tiara C. Willie, Ph.D. National Institute of Mental Health 09/01/2017 08/31/2019 F31
345 An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents Jesse N Schell National Institute of Child Health and Human Development 05/01/2016 08/31/2019 R42
346 An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents Lynn E. Fiellin, M.D. National Institute of Child Health and Human Development 05/01/2016 08/31/2019 R42
347 "Doctoring": Assisted Injection Practices Among Injection Drug Users Sarah Brothers, M.A.;M.Phil National Science Foundation 09/01/2016 08/31/2019 Fellowship
348 Multi-State Study of Factors Affecting the Implementation and Utilization of Partner Services for HIV-Positive MSM (Project PS) Paul D. Cleary, Ph.D. National Institute of Mental Health 05/10/2018 02/29/2020 CIRA Pilot Project
349 Multi-State Study of Factors Affecting the Implementation and Utilization of Partner Services for HIV-Positive MSM (Project PS) Margaret R. Weeks, Ph.D. National Institute of Mental Health 05/10/2018 02/29/2020 CIRA Pilot Project
350 Multi-State Study of Factors Affecting the Implementation and Utilization of Partner Services for HIV-Positive MSM (Project PS) Jacob van den Berg, Ph.D, M.S. National Institute of Mental Health 05/10/2018 02/29/2020 CIRA Pilot Project
351 Preventing HIV/AIDS by Building Capacity to Reduce Stigma Among Providers for Pregnant Women in Rural Haiti Jasmine Abrams, Ph.D. Fogarty International Center 07/01/2018 04/30/2020 R21
352 Research Education Institute for Diverse Scholars (REIDS) Trace Kershaw, Ph.D. National Institute of Mental Health 09/01/2015 05/31/2020 R25
353 HIV/STI Risk Behaviors, Mental Health, and Immigration: The Experiences of Immigrants Pre- and Post-Migration Sarah Abboud, Ph.D. Research Education Institute for Diverse Scholars (REIDS) 05/02/2018 05/31/2020 REIDS Pilot Project
354 Exploring Transgender Women’s Perceptions of E-Health Technology for Sexual Health Care Support Keosha T. Bond, Ed.D., M.P.H., CHES Research Education Institute for Diverse Scholars (REIDS) 05/06/2019 05/31/2020 REIDS Pilot Project
355 Provider-initiated HIV Prevention and Sexual Health Promotion with Couples Natalie Leblanc, Ph.D., M.P.H., R.N., B.S.N. Research Education Institute for Diverse Scholars (REIDS) 02/01/2019 05/31/2020 REIDS Pilot Project
356 Generating Knowledge for the Development of a Culturally Tailored Intergenerational Triad Intervention to Reduce Substance Abuse and Improve Psychological Wellness and HIV Outcomes in African American Women Living in the Deep South LaDrea Ingram, Ed.D., CHES Research Education Institute for Diverse Scholars (REIDS) 06/03/2019 06/02/2020 REIDS Pilot Project
357 Project CIRCLE: CIRA International HIV Research Capacity and Collaboration: An Exploratory Study Kaveh Khoshnood, Ph.D., M.P.H. National Institute of Mental Health 06/03/2019 06/02/2020 CIRA Pilot Project
358 Project CIRCLE: CIRA International HIV Research Capacity and Collaboration: An Exploratory Study Dini Harsono, M.Sc. National Institute of Mental Health 06/03/2019 06/02/2020 CIRA Pilot Project
359 Developing social capital interventions to improve viral suppression and quality of life among HIV- positive aging populations in New Haven, CT Yusuf Ransome, Dr.P.H. National Institute of Mental Health 07/17/2019 07/16/2020 CIRA Pilot Project
360 Prison Interventions and HIV Prevention Collaboration Frederick L Altice, M.D. National Institute on Drug Abuse 09/01/2010 07/31/2020 R01
361 High Yield HIV testing, Facilitated Linkage to Care and Prevention for Female Youth in Kenya Ann Kurth, Ph.D., CNM, MPH, FAAN National Institute of Allergy and Infectious Diseases 08/01/2015 07/31/2020 R01
362 HIV Testing and Partner Notification Services for Women in China Cynthia X. Shi, M.Sc. National Institute of Mental Health 09/16/2018 09/15/2020 F31
363 Interrupting HIV stigma in the household using home HIV testing offers in South Africa Luke Davis, M.D. National Institute of Mental Health 09/16/2019 09/15/2020 CIRA Pilot Project
364 Interrupting HIV stigma in the household using home HIV testing offers in South Africa Mari Armstrong-Hough, M.P.H., Ph.D. National Institute of Mental Health 09/16/2019 09/15/2020 CIRA Pilot Project
365 Optimizing PrEP's Potential in Non-Clinical Settings: Development and Evaluation of a PrEP Shared Decision Making Tool for Women Seeking Domestic Violence Services Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute of Mental Health 11/15/2019 11/14/2020 CIRA Pilot Project
366 Optimizing PrEP's Potential in Non-Clinical Settings: Development and Evaluation of a PrEP Shared Decision Making Tool for Women Seeking Domestic Violence Services Tiara C. Willie, Ph.D. National Institute of Mental Health 11/15/2019 11/14/2020 CIRA Pilot Project
367 HIV Prevention Trials Network (HPTN) Sten H. Vermund, M.D., Ph.D. National Institute of Allergy and Infectious Diseases 06/01/2009 11/30/2020 UM1
368 A Unified Intervention for Young Gay and Bisexual Men’s Minority Stress, Mental Health, and HIV Risk John Pachankis, Ph.D. National Institute of Mental Health 02/15/2016 12/31/2020 R01
369 Interrupting HIV and TB Stigma in the Household During TB Contact Investigation in Uganda Luke Davis, M.D. Fogarty International Center 04/15/2019 02/28/2021 R21
370 Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings Frederick L Altice, M.D. National Institute on Drug Abuse 08/15/2016 04/30/2021 R01
371 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer Amy C. Justice, M.D., M.Sc., Ph.D. National Cancer Institute 07/01/2016 05/31/2021 R01
372 The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction Sandra Springer, M.D. National Institute on Drug Abuse 09/01/2016 05/31/2021 R01
373 Understanding the impact of COVID-19 on individuals with HIV with tobacco use: A mixed-methods Study Eva Jennifer Edelman, M.D. National Institute of Mental Health 06/08/2020 06/07/2021 CIRA Pilot Project
374 Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine Frederick L Altice, M.D. National Institute on Drug Abuse 09/15/2016 06/30/2021 R01
375 IMPART: A Provider-Assisted HIV Partner Notification & Testing Intervention for Prisoners in Indonesia Gabriel John Culbert, Ph.D. National Institute of Mental Health 09/14/2018 06/30/2021 R34
376 Evaluating the Role of Opioid Medication Assisted Therapies in HIV-1 Persistence for Persons Living with HIV and Opioid Use Disorders Sandra Springer, M.D. National Institute on Drug Abuse 09/01/2018 07/31/2021 R61
377 Network-Based Epidemiology for Hidden and Hard-To-Reach Populations Forrest W. Crawford, Ph.D. Office of the Director, National Institutes of Health 09/14/2016 08/31/2021 DP2
378 Optimizing ACT Use for African Children in the Setting of HIV and Malnutrition Fran Aweeka Eunice Kennedy Shriver National Institute of Child Health and Human Development 12/23/2010 08/31/2021 RO1
379 Training in Nursing Interventions for HIV and Addiction in Criminal Justice Settings Gabriel John Culbert, Ph.D. National Institute on Drug Abuse 09/01/2017 08/31/2021 K23
380 A Digital Intervention for HIV Prevention in Black Adolescent Girls Kimberly Hieftje, Ph.D. Eunice Kennedy Shriver National Institute of Child Health and Human Development 09/01/2019 08/31/2021 R21
381 A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-Based Health Centers Lynn E. Fiellin, M.D. National Institute on Drug Abuse 09/30/2019 08/31/2021 UG3
382 Social Capital and Late HIV Diagnosis in the United States Yusuf Ransome, Dr.P.H. National Institute of Mental Health 04/06/2017 03/31/2022 K01
383 Structural Stigma and HIV Risk in a Representative Cohort of Gay and Bisexual Men John Pachankis, Ph.D. National Institute of Mental Health 07/19/2017 04/30/2022 R01
384 Structural Stigma and HIV Risk in a Representative Cohort of Gay and Bisexual Men Mark Hatzenbuehler, Ph.D. National Institute of Mental Health 07/19/2017 04/30/2022 R01
385 Using Smart Phones to Understand the Link Between Social and Geographical Context and HIV Risk Behavior Among MSM Trace Kershaw, Ph.D. National Institute of Child Health and Human Development 09/01/2017 04/30/2022 R01
386 Using Smart Phones to Understand the Link Between Social and Geographical Context and HIV Risk Behavior Among MSM Nathan B Hansen, Ph.D. National Institute of Child Health and Human Development 09/01/2017 04/30/2022 R01
387 Developing an Artificial Intelligence Chatbot to Promote HIV Testing Frederick L Altice, M.D. National Institute of Allergy and Infectious Diseases 06/16/2020 05/31/2022 R21
388 Developing efficient intervention technologies to reduce stigma related stress, mental health problems, and HIV risk among young Chinese MSM John Pachankis, Ph.D. Fogarty International Center 08/01/2020 06/30/2022 R21
389 Preparing for Pre-Exposure Prophylaxis Implementation in Central-Eastern European Countries with Low Access to Biomedical Prevention John Pachankis, Ph.D. Fogarty International Center 09/09/2020 06/30/2022 R21
390 Phylodynamic Analysis of HIV Transmission Clusters in Kazakhstan for Targeted Interventions Sten H. Vermund, M.D., Ph.D. National Institute on Drug Abuse 07/15/2020 06/30/2022 R03
391 Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia Zhao Ni, Ph.D. Fogarty International Center 09/11/2020 06/30/2022 R21
392 Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia Frederick L Altice, M.D. Fogarty International Center 09/11/2020 06/30/2022 R21
393 Development and testing of a mobile application to enhance HIV prevention cascade in Malaysian MSM Roman Shrestha, Ph.D., M.P.H. Fogarty International Center 09/11/2020 06/30/2022 R21
394 Integrated rapid access to HIV prevention program for people who inject drugs (iRaPID) Roman Shrestha, Ph.D., M.P.H. National Institute on Drug Abuse 08/01/2020 07/31/2022 R21
395 Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia Frederick L Altice, M.D. National Institute on Drug Abuse 09/30/2020 08/31/2022 R21
396 Longitudinal Exploration of Pathways to HIV/STI Risk Reduction among Homeless Young Adults through a Youth-Centric Rapid Re-Housing Program Heather Mosher, Ph.D. National Institute of Mental Health 09/01/2020 08/31/2022 R21
397 The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: A Geospatial, Genomic and Social Network Study Ted Cohen, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 01/17/2018 12/31/2022 R01
398 TB and Other Pulmonary Complications of AIDS Research Training Program Luke Davis, M.D. Fogarty International Center 08/01/2013 03/31/2023 D43
399 Improving HIV testing and PrEP for transgender women through mHealth Jeffrey A. Wickersham, Ph.D. National Institute of Allergy and Infectious Diseases (NIAID) 04/28/2021 03/31/2023 R21
400 Improving HIV testing and PrEP for transgender women through mHealth Roman Shrestha, Ph.D., M.P.H. National Institute of Allergy and Infectious Diseases (NIAID) 04/28/2021 03/31/2023 R21
401 Evaluations of Medication Assisted Treatments for Substance Use Disorders Among Persons Living with and at Risk for HIV Infection Sandra Springer, M.D. National Institute on Drug Abuse 05/01/2018 04/30/2023 K02
402 Building Mobile HIV Prevention and Mental Health Support in Low-Resource Settings John Pachankis, Ph.D. National Institute of Mental Health 09/05/2018 06/30/2023 R01
403 Coordinated Medical Treatment of Opioid Use Disorder and Infectious Disease Sandra Springer, M.D. National Center for Advancing Translational Sciences 07/18/2019 06/30/2023 U01
404 Multi-Level Intervention Addressing Intersectional Stigma to Improve HIV Testing in MSM LaRon E. Nelson, PhD, RN, FNP, FNAP, FAAN National Institute of Nursing Research 09/05/2019 06/30/2023 R01
405 Implementation of Seek, Test, Treat & Retain Strategies among People Who Inject Drugs in Malaysia Marek Chawarski, Ph.D. National Institute on Drug Abuse 09/01/2018 07/31/2023 R01
406 Understanding Relapse and the Impact of Social Networks and Geographic Settings During Treatment for Alcohol-Related Problems Trace Kershaw, Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/20/2018 08/31/2023 R01
407 Developing e-Covery: An App-Based Intervention to Support Recovery from Co-occurring Alcohol Use and Opioid Use Adam Viera, M.P.H. National Institute on Alcohol Abuse and Alcoholism 09/01/2020 08/31/2023 F31
408 Human-Centered Design and Communities of Practice to Improve Delivery of Home-Based TB Contact Investigation in Uganda Luke Davis, M.D. National Institute of Allergy and Infectious Diseases 06/17/2013 12/31/2023 R01
409 Biopsychosocial Mechanisms Underlying Internalizing Psychopathology in a Prospective, Population-Based Cohort of Sexual Minority Young Adults John Pachankis, Ph.D. National Institute of Mental Health 03/01/2019 12/31/2023 R01
410 Mental Illness Stigma as a Risk Factor for Substance Use among Adults with Depression Katie Wang, Ph.D. National Institute on Drug Abuse 02/01/2019 01/31/2024 K01
411 Exploring the Feasibility of a Peer-driven Intervention to Improve HIV Prevention Among Prisoners Who Inject Drugs Julia Rozanova, Ph.D. National Institute On Drug Abuse 03/15/2019 02/29/2024 K01
412 Long-Acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-Involved Adults Sandra Springer, M.D. National Institute on Drug Abuse 08/01/2019 04/30/2024 U01
413 Novel, Adaptive Approaches to Predicting and Responding to Outbreaks of Overdose, HIV and HCV among People Who Use Drugs Gregg Gonsalves, Ph.D. National Institute on Drug Abuse 07/01/2019 05/31/2024 DP2
414 Engaging Providers, Community Members, and Young Women to Adapt and Pilot a Youth-Friendly Sexual and Reproductive Health Package in Low-Income Communities in India Marie Brault, Ph.D. Fogarty International Center 09/04/2020 05/31/2024 K01
415 Immunologic Profiles of Distinct Cognitive Trajectories in Adults with Perinatal HIV Payal Patel, M.D. National Institute of Mental Health 07/11/2019 06/30/2024 K23
416 Multidrug-resistant Tuberculosis and HIV: Composition of Strains and Biomarkers of Treatment Response Patrick Cudahy, M.D. Fogarty International Center 09/16/2019 06/30/2024 K01
417 Integrating Genomic and Spatial Approaches for Targeted Control of HIV-Associated Tuberculosis Epidemics Ted Cohen, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 08/01/2020 07/31/2024 R01
418 Intersectional Stigma, Mental Health, and HIV Risk among US Gay and Bisexual Men of Color Skyler Jackson, Ph.D. National Institute of Mental Health 08/05/2020 07/31/2024 K01
419 A Smart Approach to Treating Tobacco Use Disorder in Persons Living with HIV Eva Jennifer Edelman, M.D. National Cancer Institute 09/19/2019 08/31/2024 R01
420 Identifying Modifiable Risk and Protective Processes at the Day-Level that Predict HIV Care Outcomes Among Women Exposed to Partner Violence Tami P. Sullivan, Ph.D. National Institute of Mental Health 01/01/2020 11/30/2024 R01
421 Identifying Modifiable Risk and Protective Processes at the Day-Level that Predict HIV Care Outcomes Among Women Exposed to Partner Violence Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute of Mental Health 01/01/2020 11/30/2024 R01
422 HIV Co-morbidities Research Training in Ghana (HIV-COMRT) Elijah Paintsil, M.D. Fogarty International Center 06/15/2020 12/31/2024 D43
423 Malaysian Implementation Science Training (MIST) Program in HIV Frederick L Altice, M.D. Fogarty International Center 04/22/2020 12/31/2024 D43
424 Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management with PrEP Navigation Eva Jennifer Edelman, M.D. National Institute on Drug Abuse 07/01/2020 05/31/2025 R01
425 Enhancing Surveillance Systems to Slow the Spread of Antimicrobial-Resistant Gonorrhea in the United States Reza Yaesoubi, Ph.D. National Institute of Allergy and Infectious Diseases 06/23/2020 05/31/2025 R01
426 Training in mHealth Prevention with MSM Roman Shrestha, Ph.D., M.P.H. National Institute on Drug Abuse 07/15/2020 06/30/2025 K01
427 Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2 Elijah Paintsil, M.D. Eunice Kennedy Shriver National Institute of Child Health and Human Development 08/15/2020 06/30/2025 R01
428 Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations Sandra Springer, M.D. National Institute on Drug Abuse 09/30/2020 07/31/2025 U01
429 Development and Validation of a Novel and HIV-Relevant Prediction Model for Fracture Evelyn Hsieh, M.D., Ph.D. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS​) 04/01/2021 03/31/2026 R01